Levetiracetam in patients with epilepsy and chronic liver disease: Observations in a case series

Clinical Neuropharmacology

Volumn 31, Issue 4, 2008, Pages 221-225

  Bilo, Leonilda ^a,d   Meo, Roberta ^b   De Leva, Maria Fulvia ^a   De Simone, Roberto ^a   Di Nocera, Pietro ^b   Pisani, Francesco ^c   Striano, Salvatore ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b ASL Napoli 1   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d University of Messina ^*  (Italy)

Author keywords

Epilepsy; Levetiracetam; Liver disease

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; GAMMA GLUTAMYLTRANSFERASE; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; ALANINE AMINOTRANSFERASE; ANTICONVULSIVE AGENT; ASPARTATE AMINOTRANSFERASE; DRUG DERIVATIVE; PIRACETAM;

ABSENCE; ADD ON THERAPY; ADULT; ALCOHOL LIVER CIRRHOSIS; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD CHEMISTRY; CASE STUDY; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL PRACTICE; COMPLEX PARTIAL SEIZURE; CONFUSION; CONTROLLED STUDY; DROWSINESS; DRUG DOSE TITRATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENZYME ACTIVITY; EPILEPSY; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEADACHE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEIZURE; SIMPLE PARTIAL SEIZURE; TONIC CLONIC SEIZURE; TREATMENT RESPONSE; BLOOD; CHRONIC DISEASE; CLINICAL TRIAL; LIVER FUNCTION TEST; VIRUS HEPATITIS;

ALANINE TRANSAMINASE; ANTICONVULSANTS; ASPARTATE AMINOTRANSFERASES; CHRONIC DISEASE; EPILEPSY; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; PIRACETAM; PROSPECTIVE STUDIES; SEIZURES;

EID: 53449099859     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e31815c1d92     Document Type: Article

References (8)

1. Ahmed SN, Siddiqi ZA. Antiepileptic drugs and liver disease. Seizure 2006;15:156-164.
2. French J. Use of levetiracetam in special populations. Epilepsia 2001;42(suppl 4):40-43.
3. Patsalos PN. Clinical pharmacokinetics of levetiracetam. Clin Pharmacokinet 2004;43(11): 707-724.
4. Chabolla DR, Harnois DM, Meschia JF. Levetiracetam monotherapy for liver transplant patients with seizures. Transplant Proc 2003;35(4):1480-1481.
5. Glass GA, Stankiewicz J, Mithoefer A, et al. Levetiracetam for seizures after liver transplantation. Neurology 2005;64(6):1084-1085.
6. Patsalos PN, Ghattaura S, Ratnaraj N, et al. In situ metabolism of levetiracetam in blood of patients with epilepsy. Epilepsia 2006;47(11):1818-1821.
7. Johannessen SL, Tomson T. Pharmacokinetic variability of newer AEDs. Clin Pharmacokinet 2006; 45:1061-1075.
8. Brockmoller J, Thomsen T, Wittstock M, et al. Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function tests. Clin Pharmacol Ther 2005;6: 529-541.